This present study investigated the microbial dynamics, physicochemical and functional properties, and sensory characteristics of kefir produced by two different approaches: traditional kefir obtained directly from grains and kefir manufactured through a double-fermentation process in cow milk. For the first fermentation, kefir grains were inoculated in milk at different levels (1%, 3%, and 5% w/v) and incubated at 30 °C for 24 h. The lowest inoculation level promoted the greatest increase in grain biomass, whereas higher inoculation levels produced more pronounced pH decreases. All products maintained stable pH values during refrigerated storage at 4 °C for 15 days. Products derived from initial fermentations with 1% and 3% inoculum were subsequently used in a second fermentation step at two inoculation levels (1% and 10% v/v) to produce double-fermentation kefir products. These products exhibited higher counts of lactic acid bacteria and reduced yeast populations compared with traditional grain kefir. After 15 days of storage, all kefir samples maintained more than 108 CFU/mL of lactic acid bacteria, more than 107 CFU/mL of acetic acid bacteria, and around 105 CFU/mL of yeasts. Protein content was comparable among all kefir products and unfermented milk. The product obtained with 1% grains followed by 10% v/v inoculation showed enhanced biofilm formation that increased during storage and displayed the strongest antimicrobial activity, and was therefore selected for sensory evaluation, where it achieved favorable acceptance by regular kefir consumers.
Aflatoxin B1 (AFB1), a potent carcinogenic metabolite produced by Aspergillus flavus and A. parasiticus, constitutes a significant threat to food safety. Conventional decontamination methods are costly or ineffective. Biological detoxification has emerged as a promising alternative. Kefir, a fermented milk beverage, comprises lactic acid bacteria (LAB) and yeasts with documented antifungal properties. This study evaluated whey permeate (WP) as a fermentation substrate for kefir microorganisms and assessed their AFB1-binding capacity. Kefir microorganisms cultivated in WP supported active fermentation, reaching 8.47 log CFU/mL LAB and 7.57 log CFU/mL yeasts, with concomitant lactose consumption and organic acid production. The ability of 13 individual kefir-derived microorganisms and the total kefir microbial community to bind AFB1 was evaluated under diverse conditions. All microorganisms exhibited AFB1 binding ability, although binding depended on strain, growth medium, pH, microbial concentration, and toxin concentration. The highest binding was observed for the total kefir community grown in WP. Binding remained stable over time for the total kefir community and Lactiplantibacillus plantarum CIDCA 83114 and was independent of viability and hydrophobicity. AFB1 binding by kefir microorganisms significantly reduced AFB1-induced cytotoxicity in HepG2 cells. These findings demonstrate that WP can be valorized into a value-added fermented product containing microorganisms with strong AFB1 binding and cytoprotective properties.
Lactiplantibacillus species are widely recognized for their probiotic potential, yet the genetic determinants underlying strain-specific functional traits remain incompletely characterized. This study aimed to obtain the draft genome sequence of Lactiplantibacillus plantarum CIDCA 83114, a kefir-derived strain with previously demonstrated probiotic and antimicrobial properties, and to identify genetic features potentially associated with these traits and with strain safety. Whole-genome sequencing was performed on an Illumina MiSeq platform, genome assembly was generated using SPAdes, and functional annotation was conducted using Prokka and KEGG-based tools. The genome comprises a 3.27 Mb chromosome and five putative plasmid sequences. KEGG analysis identified 36 complete metabolic pathways, including biosynthetic routes for amino acid and vitamin biosynthesis. A plantaricin gene cluster was identified, consistent with the genetic potential for bacteriocin production. Core-genome phylogenetic analysis positioned Lpb. plantarum CIDCA 83114 among dairy-associated Lpb. plantarum isolates. Importantly, genomic screening revealed no acquired antibiotic-resistance or virulence-associated genes. The few resistance-related loci detected were annotated as resistance-associated but could not be confirmed as acquired resistance determinants; they were chromosomally located and showed no association with the plasmid sequences or prophage-associated regions identified in this assembly. Overall, the genomic features identified in Lpb. plantarum CIDCA 83114 provide a molecular basis consistent with its previously characterized metabolic, probiotic, and antimicrobial properties, while supporting its genomic safety profile.